Over 8,000 years ago, early farming communities in northern Mesopotamia were already thinking mathematically—long before ...
Early in her career, author Emma Grey felt like rejection would break her. Today, she’s made rejection something to reach for ...
Abemaciclib monotherapy benefited 33% of patients with HR-positive, HER2-negative breast cancer post-CDK4/6 inhibitor progression. Abemaciclib shows promise as a monotherapy for HR-positive, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback